Driven by Extraordinary
Expertise and Commitment
Technology is only as powerful as the minds who harness it—that’s the human element of drug development. Our team is made up of veteran drug hunters with a unique mastery of immune biology. With a proven track record in discovering breakthrough medicines and building biopharma companies, Odyssey is on a mission to revolutionize treatments in immunology. Focused, driven, and relentless, bold ideas are becoming life-changing realities.
Leadership
“This is a culture of ‘can do,’ a culture of respect, and a culture of trying to make a difference. The problems we are solving will extend and improve the lives of real people and real families around the world.”
Visionary Investors
Since our founding in 2021 by OrbiMed and SR One, Odyssey Therapeutics has attracted more than $500 million in funding from a diverse investor syndicate with a mix of funds and investment strategies.
Join Our Odyssey
If you’re ready to be part of something extraordinary, explore our career opportunities or reach out to us.
